CoverageForm 410-K10-Q8-K13D13G13F

Bir Dawn Carter

CIK 0001688712
Interim President and CEODirector

Filings

19

Latest May 26, 2026

Issuers covered

4

Showing

19 of 19

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Bir Dawn Carter. Track record appears once open-market purchases or sales reach the +30 day horizon.

Issuers

Companies where Bir Dawn Carter has filed

TickerIssuerFilingsLast filed
RETAReata Pharmaceuticals Inc10Sep 26, 2023
GERNGeron Corp5May 26, 2026
SLNOSoleno Therapeutics Inc3May 18, 2026
SAVACassava Sciences Inc1Oct 22, 2025

All filings

19 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue